Engeletin alleviates doxorubicin-induced cardiotoxicity via the AMPK pathway in mice
ENG has mitigated DIC through the activation of the AMPK pathway, thereby rendering it a potential drug for the prevention and treatment of DIC.
Authors
- Dan Luo (ORCID: https://orcid.org/0000-0002-8202-7420)
- Pusong Tang
- Qingning Huang
- Yuhua Lei
- Rui Huang
- Xing Zhong
- Xin Chen
- Lu Ye
Institutions
- The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture (CN)
- Applications Research (United States) (US)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2026-02-26
- DOI
- https://doi.org/10.3389/fphar.2026.1741741
- Primary Topic
- Chemotherapy-induced cardiotoxicity and mitigation
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China